1996
DOI: 10.2214/ajr.166.6.8633437
|View full text |Cite
|
Sign up to set email alerts
|

Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
27
0
5

Year Published

1997
1997
2015
2015

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(35 citation statements)
references
References 21 publications
3
27
0
5
Order By: Relevance
“…The lesion appears hyperdense compared to the normal surrounding parenchyma during the arterial phase, and slightly hypodense during the portal phase [8], [9]. This temporal evolution is in agreement with the complex hepatic enhancement observed in in vivo examinations [4], [28]. During the first early acquisition phase (around 20-30 s after contrast infusion), the hypervascular lesion receives highly concentrated dye product coming from the HA, while the liver parenchyma is less enhanced because receiving less CM (PV does not contain CM yet), which leads to a high lesion conspicuity.…”
Section: Macroscopic Model: Application To the Liver Vascular Nesupporting
confidence: 83%
“…The lesion appears hyperdense compared to the normal surrounding parenchyma during the arterial phase, and slightly hypodense during the portal phase [8], [9]. This temporal evolution is in agreement with the complex hepatic enhancement observed in in vivo examinations [4], [28]. During the first early acquisition phase (around 20-30 s after contrast infusion), the hypervascular lesion receives highly concentrated dye product coming from the HA, while the liver parenchyma is less enhanced because receiving less CM (PV does not contain CM yet), which leads to a high lesion conspicuity.…”
Section: Macroscopic Model: Application To the Liver Vascular Nesupporting
confidence: 83%
“…For example, hyper-vascular hepatic lesions are better detectable during the pure arterial phase when the contribution of the portal blood supply is not preponderant yet. But the duration of this phase is di cult to estimate [5]. This is mainly due to the variations of the hepatic enhancement, with a large number of parameters (type and quantity of contrast material, injection ow and duration, monophasic or biphasic injection) or the tumor types [6].…”
Section: State Of the Artmentioning
confidence: 99%
“…For arterial phase CT imaging the injection rate and the scanning delay are critical, because the arterial phase lasts only a short time [8]. In recent years experienced authors recommended at least 4.0 ml/s to achieve a sufficient conspicuity of arterial enhancing tumors [2,4,7].…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the precontrast and postcontrast density of the aorta and of the spleen was determined. As previously determined by other authors [8,18], the duration of the arterial phase was determined by measuring the contrast enhancement in liver parenchyma.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation